Skip to main content
Log in

Intestinal overexpression of ZNF148 suppresses ApcMin/+ neoplasia

  • Original Contributions
  • Published:
Mammalian Genome Aims and scope Submit manuscript

Abstract

ZNF148 (ZBP-89, Zfp148) is a multifunctional transcription factor expressed at low levels in most tissues. When overexpressed in gastrointestinal cancer cell lines, ZNF148 inhibits cellular proliferation and induces apoptosis. We sought to determine whether intestinal ZNF148 overexpression would abrogate adenoma development in the ApcMin/+ mouse, i.e., whether ZNF148 is a tumor suppressor. The 13-kb villin promoter was spliced upstream of the ZNF148 cDNA to generate transgenic villin-ZNF148 (ZNF148TgVZ) mice. Intestinal mucosal ZNF148 expression was elevated in four of five ZNF148TgVZ lineages and correlated with increased caspase-3 expression and activation. In addition, DNA fragmentation was increased in ZNF148TgVZ mice relative to wild-type littermates. These results suggested that increased intestinal ZNF148 expression induces apoptosis. ZNF148TgVZ mice were crossed with ApcMin/+ mice to assess the biological significance of intestinal ZNF148 overexpression. The presence of the ZNF148TgVZ allele in ApcMin/+ mice correlated with reduced gastrointestinal bleeding at 5 weeks, a 50% reduction in adenoma burden at 20–22 weeks, and prolonged survival (median survival of 33.5 days vs. 21.5 days), relative to nontransgenic littermates. These data suggest that enhanced ZNF148 expression activates intestinal apoptosis and thereby mitigates disease burden in ApcMin/+ mice. They also suggest that ZNF148 is a therapeutic target to inhibit colon cancer development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  • Bai L, Merchant JL (2000) Transcription factor ZBP-89 cooperates with histone acetyltransferase p300 during butyrate activation of p21waf1 transcription in human cells. J Biol Chem 275, 30725–30733

    Article  PubMed  CAS  Google Scholar 

  • Bai L, Merchant JL (2001) ZBP-89 promotes growth arrest through stabilization of p53. Mol Cell Biol 21, 4670–4683

    Article  PubMed  CAS  Google Scholar 

  • Bai L, Logsdon C, Merchant JL (2002) Regulation of epithelial cell growth by ZBP-89: potential relevance in pancreatic cancer. Int J Gastrointest Cancer 31, 79–88

    Article  PubMed  CAS  Google Scholar 

  • Chen T, Yang I, Irby R, Shain KH, Wang HG, et al. (2003) Regulation of caspase expression and apoptosis by Adenomatous Polyposis Coli. Canc Res 63, 4368–4374

    CAS  Google Scholar 

  • Johnson IT (2002) Anticarcinogenic effects of diet-related apoptosis in the colorectal mucosa. Food Chem Toxicol 40, 1171–1178

    Article  PubMed  CAS  Google Scholar 

  • Keates AC, Keates S, Kwon JH, Arseneau KO, Law DJ, et al. (2001) ZBP-89, Sp1, and nuclear factor-kappa B regulate epithelial neutrophil-activating peptide-78 gene expression in Caco-2 human colonic epithelial cells. J Biol Chem 276, 43713–43722

    Article  PubMed  CAS  Google Scholar 

  • Law DJ, Tarle SA, Merchant JL (1998a) The human ZBP-89 homolog, located at chromosome 3q21, represses gastrin gene expression. Mammal Genome 9, 165–167

    Article  CAS  Google Scholar 

  • Law GL, Itoh H, Law DJ, Mize GJ, Merchant JL, et al. (1998b) Transcription factor ZBP-89 regulates the activity of the ornithine decarboxylase promoter. J Biol Chem 273, 19955–19964

    Article  CAS  Google Scholar 

  • Law DJ, Labut EM, Adams RD, Merchant JL (2006) An isoform of ZBP-89 predisposes the colon to colitis. Nucleic Acids Res 34, 1342–1350

    Article  PubMed  CAS  Google Scholar 

  • Madison BB, Dunbar L, Qiao XT, Braunstein K, Braunstein E, et al. (2002) Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J Biol Chem 277, 33275–33283

    Article  PubMed  CAS  Google Scholar 

  • Mähler M, Bristol IJ, Leiter EH, Workman AE, Birkenmeier EH, et al. (1998) Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol 274, G544–G551

    PubMed  Google Scholar 

  • Merchant JL, Iyer GR, Taylor BR, Kitchen JR, Mortensen ER, et al. (1996) ZBP-89, a Kruppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter. Mol Cell Biol 16, 6644–6653

    PubMed  CAS  Google Scholar 

  • Moser AR, Pitot HC, Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322–324

    Article  PubMed  CAS  Google Scholar 

  • Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AC, et al. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668–670

    Article  PubMed  CAS  Google Scholar 

  • Takeuchi A, Mishina Y, Miyaishi O, Kojima E, Hasegawa T, et al. (2003) Heterozygosity with respect to Zfp148 causes complete loss of fetal germ cells during mouse embryogenesis. Nat Genet 33, 172–176

    Article  PubMed  CAS  Google Scholar 

  • Trock B, Lanza E, Greenwald P (1990) Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J Natl Cancer Inst 82, 650–661

    PubMed  CAS  Google Scholar 

  • Wang X, Brown IL, Khaled D, Mahoney MC, Evans AJ, et al. (2002) Manipulation of colonic bacteria and volatile fatty acid production by dietary high amylose maize (amylomaize) starch granules. J Appl Microbiol 93, 390–397

    Article  PubMed  CAS  Google Scholar 

  • Zavros Y, Eaton KA, Kang W, Rathinavelu S, Katukuri V, et al. (2005) Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma. Oncogene 24, 2354–2366

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by Public Health Service NIH grants DK55732 (JLM) and DK065004 (DJL). Funding for this project was provided through the Pilot Feasibility Program (DJL) of the Michigan Gastrointestinal Peptide Research Center (2P30DK34933-20) and in part through the University of Michigan Cancer Center (5P30CA46592). The authors thank Intrexon Corporation (Roanoke, VA) for assembly of the pVillin-ZNF148 construct. Deborah Gumucio and Blair Madison generously provided the villin promoter donor plasmid. Art Tessier and Gail Kelsey provided administrative support. Scherezade Momin provided technical assistance. The authors gratefully acknowledge the expertise of the University of Michigan Transgenic Animal Model Core, especially Thom Saunders, Linda Samuelson, and Elizabeth Hughes. They also thank members of the DNA Sequencing Core, the Unit for Laboratory Animal Medicine at the University of Michigan, and Kathy McClinchey for assistance with histology preparation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Juanita L. Merchant.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Law, D.J., Labut, E.M. & Merchant, J.L. Intestinal overexpression of ZNF148 suppresses ApcMin/+ neoplasia. Mamm Genome 17, 999–1004 (2006). https://doi.org/10.1007/s00335-006-0052-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00335-006-0052-4

Keywords

Navigation